Forest-Gedeon Richter drug misses overall goal
September 1st, 2010
More info…
TEL AVIV (MarketWatch) — Forest Laboratories Inc. and Gedeon Richter PLC said Monday that in a Phase II study of cariprazine, a potential treatment for bipolar depression, the overall result for patients taking the drug was not statistically different from that of the patients taking placebo. In higher doses, however, the antipsychotic drug did show “evidence of a clinically relevant treatment …
Posted in Childhood Depression, Clinical Depression, Depression Types, Teenage Depression | Comments (0)
Bipolar Advantage Announces New Program ‘Providing Solutions to the Bipolar Economy’
August 31st, 2010
Posted in Childhood Depression, Severe Depression | Comments (0)
Why believers in immortality must read Super Sad True Love Story
August 30th, 2010
More info…
Transhumanists! Singularitarians! Listen up! You who harbor a fervent faith in sciences imminent transformation of our frail, fleshy selves. The conquest of all our physical and mental ailments, cancer, Alzheimers, schizophrenia, depression, senescence–death itself. You who exult over every breakthrough in nanotech, biotech, neuro-prostheses, artificial intelligence bearing you closer to …
Posted in Childhood Depression | Comments (0)
Tags
Categories
Recent Posts
- Troubles belie prominent Houston doc’s family-man image
- Bipolar disorder ‘not to blame for violent behaviour’
- Lack of Sleep Can Cause Depression, Weight Gain
- Forest Labs, Gedeon Richter announce phase II study results of cariprazine for bipolar depression
- Free course helps families cope with mental illness